Avation Medical Announces US FDA 510(k) Clearance for The Vivally® System, a wearable bladder control therapy and mobile app to treat patients with urinary urgency and urge urinary incontinence.

About Avation Medical

The Avation Medical team is driven by a mission to bring to market patient-friendly systems that make the promise of neuromodulation more accessible to patients and their physicians. Our leaders and team members have decades of success in medical technology, neuromodulation and digital health and are working hard to develop solutions that return quality of life to patients across a variety of clinical conditions.

Corporate Contact

Jackie Gerberry

Senior Director, Finance

Jgerberry@Avation.com

www.Avation.com